Literature DB >> 9186145

Tuberculous meningitis at a large inner-city medical center.

M T Porkert1, M Sotir, P Parrott-Moore, H M Blumberg.   

Abstract

Tuberculosis in the United States has become primarily an inner-city disease. We examined the epidemiology of culture-confirmed tuberculous meningitis among patients cared for at an urban public hospital in Atlanta. During an 11.5-year period (January 1984-June 1995) cerebrospinal fluid cultures for Mycobacterium tuberculosis were positive in 34 patients, accounting for 1.5% of all culture-confirmed tuberculosis cases. All patients were born in the United States, 31 (91%) were black, 16 (47%) of 34 were human immunodeficiency virus (HIV) seropositive, 9 (26.5%) were HIV seronegative, and 9 (26.5%) had an unknown HIV serostatus. No significant differences were seen in clinical presentation, cerebrospinal fluid, or other laboratory data between HIV seropositive and HIV seronegative/ unknown groups, except for a lower serum white blood cell count among HIV seropositive patients. Mortality was striking; 14 (41.2%) died because of tuberculous meningitis despite appropriate therapy initiated a mean of 3 days after admission. Six survivors had permanent neurologic sequelae. Univariate analysis of outcome was not statistically associated with any measured demographic, laboratory value, stage at presentation, treatment regimen, or HIV serostatus. Multivariate analysis of outcome using 13 independent variables also demonstrated no significant association between these variables and outcome, although a trend was seen for increased mortality for white people (P = 0.09) and increasing age (P = 0.09). Tuberculous meningitis among inner-city residents remains a devastating disease associated with high morbidity and mortality that has changed little during the past 4 decades. HIV infection does not change markedly the clinical presentation or the response to therapy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9186145     DOI: 10.1097/00000441-199706000-00002

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  24 in total

1.  Mortality associated with central nervous system tuberculosis.

Authors:  Hana M El Sahly; Larry D Teeter; Xi Pan; James M Musser; Edward A Graviss
Journal:  J Infect       Date:  2007-10-17       Impact factor: 6.072

2.  Presentation and outcome of tuberculous meningitis among children: experiences from a tertiary children's hospital.

Authors:  Nicolette Nabukeera-Barungi; Jo Wilmshurst; Muloiwa Rudzani; James Nuttall
Journal:  Afr Health Sci       Date:  2014-03       Impact factor: 0.927

3.  Diabetes mellitus and risk of all-cause mortality among patients with tuberculosis in the state of Georgia, 2009-2012.

Authors:  Matthew J Magee; Mary Foote; David M Maggio; Penelope P Howards; K M Venkat Narayan; Henry M Blumberg; Susan M Ray; Russell R Kempker
Journal:  Ann Epidemiol       Date:  2014-02-08       Impact factor: 3.797

Review 4.  Tuberculosis of the central nervous system in immunocompromised patients: HIV infection and solid organ transplant recipients.

Authors:  Christina A Nelson; Joseph R Zunt
Journal:  Clin Infect Dis       Date:  2011-09-29       Impact factor: 9.079

5.  Use of IMiD3, a thalidomide analog, as an adjunct to therapy for experimental tuberculous meningitis.

Authors:  Liana Tsenova; Bande Mangaliso; George Muller; Yong Chen; Victoria H Freedman; David Stirling; Gilla Kaplan
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

Review 6.  Multidrug-resistant tuberculous meningitis.

Authors:  Thomas F Byrd; Larry E Davis
Journal:  Curr Neurol Neurosci Rep       Date:  2007-11       Impact factor: 5.081

Review 7.  Invasion of the central nervous system by intracellular bacteria.

Authors:  Douglas A Drevets; Pieter J M Leenen; Ronald A Greenfield
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

8.  Risk factors for mortality among patients with extrapulmonary tuberculosis at an academic inner-city hospital in the US.

Authors:  Ekaterina V Kourbatova; Michael K Leonard; Javier Romero; Colleen Kraft; Carlos del Rio; Henry M Blumberg
Journal:  Eur J Epidemiol       Date:  2006-10-27       Impact factor: 8.082

9.  Improved sensitivity of nucleic acid amplification for rapid diagnosis of tuberculous meningitis.

Authors:  Isik Somuncu Johansen; Bettina Lundgren; Fehmi Tabak; Björn Petrini; Salih Hosoglu; Nese Saltoglu; Vibeke Østergaard Thomsen
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

10.  Novel wide-range quantitative nested real-time PCR assay for Mycobacterium tuberculosis DNA: clinical application for diagnosis of tuberculous meningitis.

Authors:  Teruyuki Takahashi; Masato Tamura; Yukihiro Asami; Eiko Kitamura; Kosuke Saito; Tsukasa Suzuki; Sachiko Nonaka Takahashi; Koichi Matsumoto; Shigemasa Sawada; Eise Yokoyama; Toshiaki Takasu
Journal:  J Clin Microbiol       Date:  2008-03-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.